오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - doxorubicin hydrochloride -

케냐 - 영어 - Pharmacy and Poisons Board

doxorubicin hydrochloride. - concentrate for solution for infusion - 1 ml contains 2 mg doxorubicin hydrochloride - doxorubicin

미국 - 영어 - NLM (National Library of Medicine)

sun pharma global fze - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) - doxorubicin hydrochloride 2 mg in 1 ml

미국 - 영어 - NLM (National Library of Medicine)

zydus lifesciences limited - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - doxorubicin hydrochloride -

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - doxorubicin hydrochloride - concentrate for solution for infusion - 2 milligram(s)/millilitre - anthracyclines and related substances; doxorubicin